International Steering Committee to discontinue the trial’s hydroxychloroquine and the lopinavir/ritonavir arms.
Interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized #COVID19 patients when compared to the existing standard of care.
The Solidarity Trial was established by WHO to find an effective #COVID19 treatment for hospitalized patients.
Copyright: Fresh Angle International (www.freshangleng.com)
×
![]()